Revenue segments as reported by the company.

Premium and service revenues

Premium tax

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Depreciation

Amortization of acquired intangible assets

Premium tax expense

Health insurer fee expense

Impairment

Legal settlement

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Centene

Centene Corp. operates as a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Managed Care and Specialty Services. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Centene exceeds earnings guidance, eyes growth in Marketplace products

Centene's Q4 2022 earnings call highlighted robust financial performance, successful execution of value-creation plans, and a focus on operational efficiency. While challenges in Medicare Advantage margins are anticipated, opportunities in the Marketplace business and cost-cutting initiatives offer avenues for growth. Strategic initiatives to address demographic shifts and enhance care relationships position Centene for future success.

Centene reports strong Q1 earnings, focuses on growth opportunities

Centene's Q1 performance reflects strength in financial results and a strategic outlook for future growth.
Despite challenges in Medicare profitability and Medicaid redeterminations, Centene remains focused on maximizing membership and maintaining high margins.
Opportunities in enhancing relationships, investing in infrastructure, and updating margin assumptions position Centene for long-term success.

Centene reports strong Q2 earnings, raises 2023 outlook amidst challenges

Centene's Q2 earnings call showcased robust financial performance, operational efficiencies, and strategic wins in Medicaid and Marketplace segments. While facing challenges in cost trends and Star ratings strategy, the company is well-positioned for growth through revenue expansion and value-creation initiatives. Opportunities for engagement with key stakeholders and successful outreach efforts present avenues for continued success.

Centene exceeds Q3 earnings expectations, eyes growth opportunities in 2024

Centene's Q3 2023 earnings call highlighted strong financial performance, progress in Medicaid redeterminations, and operational advancements. The company anticipates continued growth in adjusted EPS for 2023 and 2024, with a focus on margin expansion and operational efficiencies. Challenges include managing membership declines and addressing questions on business plans and cost implications.

Centene exceeds 2023 expectations, poised for growth in 2024

Centene's 2023 performance was strong, exceeding expectations and positioning the company for continued growth. Key initiatives in Medicaid, Medicare Advantage, and Marketplace are driving revenue growth and operational efficiency. Challenges in managing utilization trends and achieving target margins require ongoing attention.

Centene surpasses Q1 earnings expectations, eyes growth in Medicaid and Marketplace

Centene's Q1 performance exceeded expectations, showcasing strength in Medicaid and Marketplace segments.
While facing challenges in contract protests and operational clarity, the company's strategic focus on Medicare Advantage and growth opportunities remain key strengths.
With a robust financial outlook and ongoing initiatives for optimization, Centene is well-positioned for continued success in the healthcare market.
Investors can be optimistic about Centene's growth trajectory, supported by strong operational performance and strategic initiatives.

Centene reports robust Q2 earnings, eyes Medicaid rebound and Medicare growth

Centene's Q2 2024 earnings call highlighted strong performance, Medicaid challenges, and growth opportunities in Medicaid and Medicare markets. Leadership transitions and focus on program innovation are key areas of development for the company.

Centene surpasses Q3 earnings expectations, eyes growth amid challenges

Centene's Q3 performance exceeded expectations, driven by improvements in Medicaid and strong Medicare and Marketplace segments.
Despite challenges in Medicaid and competitive pressures, Centene remains confident in its future growth and operational enhancements.
The company's strategic focus on AI, margin expansion, and quality improvement positions it well for continued success and profitability.
Analyst inquiries and company responses highlighted key areas of focus and potential areas for improvement and growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Centene Corp (NYSE:CNC ) Q2 2022 Earnings Conference Call July 26, 2022 8:30 AM ET Company Participants Jennifer Gilligan - SVP, IR Sarah London - CEO & Director Brent Layton - President & COO Andrew Asher - EVP & CFO Conference Call Participants Joshua Raskin - Nephron Research A.J. Rice - Crédit Suisse Matthew Borsch - BMO Capital Markets Justin Lake - Wolfe Research Scott Fidel - Stephens Inc. Calvin Sternick - JPMorgan Chase & Co. Nathan Rich - Goldman Sachs Group Gary Taylor - Cowen and Company Kevin Fischbeck - Bank of America Merrill Lynch Benjamin Flox - Jefferies Lance Wilkes - Sanford C.

Centene Corp (CNC) CEO Sarah London on Q2 2022 Results - Earnings Call Transcript

Centene (CNC) delivered earnings and revenue surprises of 2.31% and 1.06%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Centene (CNC) Q2 Earnings and Revenues Beat Estimates

-- Diluted Loss Per Share of $(0.29), including real estate charge; Adjusted Diluted EPS of $1.77 -- Total revenues up 16% from the second quarter of 2021 driven by organic Medicaid and Medicare growth. Health benefits ratio (HBR) of 86.7%, largely driven by Marketplace.

CENTENE CORPORATION REPORTS SECOND QUARTER 2022 RESULTS

Centene's (CNC) second-quarter results are likely to reflect growth in premiums.

Centene (CNC) Gears Up for Q2 Earnings: What Lies Ahead?

Centene  to sell its continental European businesses to Vivalto Sant é  Another milestone in Centene's value creation program and ongoing portfolio review ST. LOUIS , July 25, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today that as part of its previously announced review of strategic alternatives for its international portfolio, it has signed a definitive agreement to sell to Vivalto Santé its Spanish and Central European businesses, which include: Ribera Salud, a healthcare provider in Spain, which operates hospitals and provides other healthcare services, including through public-private partnerships; Torrejón Salud (Torrejón), a public-private partnership in the Community of Madrid which is operated by Ribera Salud; and Pro Diagnostics Group (PDG), a subsidiary of Ribera Salud, which owns clinics providing radiology and other services in Slovakia and the Czech Republic.

CENTENE SIGNS DEFINITIVE AGREEMENT TO DIVEST ITS SPANISH AND CENTRAL EUROPEAN BUSINESSES

Centene (CNC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Centene (CNC) Earnings Expected to Grow: Should You Buy?

Community-based organizations, El Concilio and E Center, partner to provide residents of San Joaquin, Sutter and Yuba counties with fresh fruits and vegetables. SACRAMENTO, Calif.

More California Families Can Eat Healthy with Health Net's $120,000 Grant to Support Vouchers 4 Veggies Program

Centene (CNC) closes the deal to divest its pharmacy business. CNC primarily intends to pursue share repurchases with proceeds received from the transaction.

Centene (CNC) Divests Unit to Boost Focus on Core Business

ST. LOUIS , July 14, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it has successfully completed the previously announced divestiture of its pharmacy business PANTHERx to the Vistria Group, General Atlantic, and Nautic Partners. "We are pleased to close this transaction, which represents another key milestone in our value creation plan and enables us to continue focusing on our core business," said Sarah London, CEO of Centene.

CENTENE COMPLETES DIVESTITURE OF PANTHERX RARE

Centene's (CNC) Delaware subsidiary receives a contract from the State of Delaware's DHSS to efficiently serve the diversified health needs of the state's Medicaid members.

Centene (CNC) Wins Contract to Serve Delaware's Medicaid Members

Humana

Humana (HUM) and Centene (CNC) are poised to grow in the promising HMO space. We try to find out which one fares better via comparative evaluation.

HUM or CNC: Which Stock is Better-Positioned at the Moment?

Award Marks Centene's 30th Medicaid Managed Care State ST. LOUIS , July 12, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today that its subsidiary Delaware First Health has been notified of an intent to award by the State of Delaware's Department of Health and Social Services (DHSS), Division of Medicaid & Medical Assistance (DMMA), to serve its statewide Medicaid Managed Care programs.

CENTENE'S DELAWARE SUBSIDIARY AWARDED STATEWIDE MEDICAID CONTRACT

Centene (CNC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Can Centene (CNC) Keep the Earnings Surprise Streak Alive?

Local Collaboration and Timely, Complete Data Among Key Factors to Successful Local Launches, Report Finds SACRAMENTO, Calif. , July 7, 2022 /PRNewswire/ -- Health Net, one of the state's longest-serving and most experienced Medi-Cal partners, has released a report identifying early lessons learned and recommendations following the January 2022 launch of California Advancing and Innovating Medi-Cal (CalAIM).

New Issue Brief from Health Net Outlines Early Lessons Learned from the Launch of CalAIM Community Supports

ST. LOUIS , June 30, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today issued a reminder that it will release its 2022 second quarter financial results at approximately 6 a.m. (Eastern Time) on Tuesday, July 26, 2022, and will host a conference call afterwards at approximately 8:30 a.m.

CENTENE CORPORATION SCHEDULES 2022 SECOND QUARTER FINANCIAL RESULTS CONFERENCE CALL

Initiatives expanded telehealth to California's most vulnerable residents; extended physical and mental health care to those without shelter; promoted healthy child development; and improved food access and education. SACRAMENTO, Calif.

Health Net Initiatives Recognized by Institute for Medicaid Innovation for Addressing Social Determinants of Health to Improve Health Equity

Centene (CNC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Centene (CNC) Stock Jumps 6%: Will It Continue to Soar?

Currently, Centene (CNC) has $3.6 billion remaining under its share buyback program.

Centene (CNC) Raises 2022 Guidance, Ups Share Buyback Fund

Shares of Centene Corp. CNC, -1.06% rallied 1.8% in premarket trading Friday, after the health care company raised its full-year profit and revenue outlook and added $3.0 billion to its stock repurchase program. The company also said it was reducing its real estate footprint, as part of its plan to adopt "a more modern, flexible work environment.

Centene raises profit outlook, will reduce real estate footprint as it adopts modern, flexible work environment

2022 Adjusted Diluted EPS of $5.55 to $5.70 Reduces Real Estate Footprint, Resulting in Long-Term Savings and One-Time Costs Board Authorizes $3 Billion Increase to Stock Repurchase Program and New $1 Billion Debt Repurchase Program ST. LOUIS , June 17, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) will host its June investor day today.

CENTENE CORPORATION ANNOUNCES INCREASED 2022 GUIDANCE AND VALUE CREATION UPDATES

The shares of Centene Corp   (NYSE:CNC) are a far cry from their April 21, all-time high of $89.92, last seen at $77.18.

Buy The Dip On This Healthcare Stock

Innovative insurer and health equity pioneer works with MedArrive to provide vulnerable Medi-Cal members and their families access to in-home COVID-19 vaccinations SACRAMENTO, Calif. , June 15, 2022 /PRNewswire/ -- Health Net , one of California's longest serving and most experienced Medi-Cal partners, is offering in-home COVID-19 vaccinations to its most vulnerable members and their families.

At-risk Medi-Cal Members Get Access to Vaccinations Through Health Net's Unique Care Collaboration

Anthem

Select Medical Holdings

UnitedHealth Group

Rising membership and a rapidly growing aging U.S. population are likely to drive the performances of the Zacks Medical-HMO industry players. UNH, ANTM, HUM, CNC and SEM are poised to benefit from improved operational efficiencies.

5 HMO Stocks Set to Gain From Membership Growth, M&A Strategy

Centene (CNC) reported earnings 30 days ago. What's next for the stock?

Centene (CNC) Up 5.7% Since Last Earnings Report: Can It Continue?

ST. LOUIS , May 19, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) will host its next Investor Meeting in a virtual format on Friday, June 17 th, 2022. Centene Corporation's senior management will host the virtual meeting, which will be streamed live on the Company's website at www.centene.com, under the Investors section.

News for Centene Stock (CNC)